Search Results 1941-1950 of 18618 for ibs

  1. Publications - James W. Jakub, M.D. - Mayo Clinic

    Villalba MD, Letter HP, Jakub JW, Yahya A, Maimone S. Clinical significance of new suspicious enhancement on breast MRI during neoadjuvant chemotherapy.

  2. News - Benjamin D. Elder, M.D., Ph.D. - Mayo Clinic

    Search for a doctor. Benjamin D. Elder, M.D., Ph.D. Neurosurgeon. Request an Appointment · Overview · Patient Stories · News. News.

  3. A Study of Seladelpar in Subjects with Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Intolerance to Ursodeoxycholic Acid (UDCA) - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  4. Patient Stories - Philip J. Lyng, M.D. - Mayo Clinic

    Philip J. Lyng, M.D. · Internist · Pulmonologist · Sleep Medicine Specialist.

  5. JavaScript is disabled. In order to continue, we need to verify that you're not a robot. This requires JavaScript. Enable JavaScript and then reload the page.

  6. Body Weight-Based Interval Training in Sedentary Overweight and Obese Adults - Mayo Clinic

    Body-weight interval training will improve exercise capacity (peak VO2) in overweight/obese adults. Participation eligibility. Participant eligibility includes ...

  7. Health & Wellness - Page 533 of 781 - Mayo Clinic News Network

    Chances are most people are going to develop cataracts at some point in their[...] GERD / Miscarriage / ACL ...

  8. News - James W. Jakub, M.D. - Mayo Clinic

    Search for a doctor. James W. Jakub, M.D.. General Surgeon; Surgical Oncologist. Request an Appointment · Overview · News · Publications. News.

  9. Health & Wellness - Page 40 of 780 - Mayo Clinic News Network

    Editor's note: April 16 is National Healthcare Decisions Day DEAR MAYO CLINIC: My mom recently sat us down at the dinner table to talk about her[...].

  10. A Study To Assess The Efficacy And Safety Of Induction And Maintenance Therapy With Afimkibart (RO7790121) In Participants With Moderately To Severely Active Crohn's Disease - Mayo Clinic

    This Phase III, multicenter, double-blind, placebo-controlled treat-through study will evaluate the efficacy and safety of induction and maintenance therapy ...